Fred Schwarzer
2022
In 2022, Fred Schwarzer earned a total compensation of $5.3M as Chief Executive Officer, President and Director at IGM Biosciences, a 46% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $355,738 |
|---|---|
| Option Awards | $4,332,020 |
| Salary | $621,920 |
| Stock Awards | $6,782 |
| Total | $5,316,460 |
Schwarzer received $4.3M in option awards, accounting for 81% of the total pay in 2022.
Schwarzer also received $355.7K in non-equity incentive plan, $621.9K in salary and $6.8K in stock awards.
Rankings
In 2022, Fred Schwarzer's compensation ranked 584th out of 5,717 executives tracked by ExecPay. In other words, Schwarzer earned more than 89.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 584 out of 5,717 | 90th |
Division Manufacturing | 247 out of 3,111 | 92nd |
Major group Chemicals And Allied Products | 76 out of 1,410 | 95th |
Industry group Drugs | 64 out of 1,311 | 95th |
Industry Pharmaceutical Preparations | 46 out of 957 | 95th |
Source: SEC filing on April 27, 2023.
Schwarzer's colleagues
We found two more compensation records of executives who worked with Fred Schwarzer at IGM Biosciences in 2022.
News
IGM Biosciences CEO Fred Schwarzer's 2022 pay falls 46% to $5.3M
April 27, 2023
IGM Biosciences CEO Fred Schwarzer's 2021 pay jumps 94% to $9.9M
April 27, 2022
IGM Biosciences CEO Fred Schwarzer's 2020 pay jumps 574% to $5.1M
April 29, 2021
IGM Biosciences CEO Fred Schwarzer's 2019 pay jumps 46% to $757K
April 21, 2020